McFarlane Neil F.
CIK 0001681098
President and CEODirector
Filings
12
Latest Feb 10, 2026
Issuers covered
2
Showing
12 of 12
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 40% | -1.5% | -3.5% | +17.3% | -21.5% |
| 90 days | 5 | 20% | -3.6% | -4.5% | +21.6% | -26.0% |
| 180 days | 3 | 33% | -17.0% | -16.9% | +12.9% | -47.2% |
| 365 days | 2 | 0% | -6.4% | -6.4% | -6.4% | -6.4% |
Issuers
Companies where McFarlane Neil F. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ZVRA | Zevra Therapeutics, Inc. | 8 | Feb 10, 2026 |
| COLL | Collegium Pharmaceutical, Inc | 4 | May 16, 2024 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|